A review of compounds exhibiting anti-orthopoxvirus activity in animal models
- 6 January 2003
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 57 (1-2) , 41-52
- https://doi.org/10.1016/s0166-3542(02)00199-7
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Effect of 5-Iodo-2′-Deoxyuridine on Vaccinia Virus (Orthopoxvirus) Infections in MiceAntimicrobial Agents and Chemotherapy, 2002
- Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia VirusesAntimicrobial Agents and Chemotherapy, 2002
- Synthesis and Antiviral Evaluation of Analogs of Adenosine-N1-Oxide and 1-(Benzyloxy)AdenosineNucleosides and Nucleotides, 1998
- FAILURE OF CYTOSINE ARABINOSIDE IN TREATING SMALLPOX: A Double-blind StudyThe Lancet, 1974
- Anti-DNA Virus Activity of the 5′-Nucleotide and 3′,5′-Cyclic Nucleotide of 9-β-D-ArabinofuranosyladenineChemotherapy, 1973
- Branched-chain sugar nucleosides. V. Synthesis and antiviral properties of several branched-chain sugar nucleosidesJournal of Medicinal Chemistry, 1969
- ASSESSMENT OF AN ISOTHIAZOLE THIOSEMICARBAZONE IN THE PROPHYLAXIS OF CONTACTS OF VARIOLA MAJORThe Lancet, 1966
- AN ISOTHIAZOLE THIOSEMICARBAZONE IN THE TREATMENT OF VARIOLA MAJOR IN MAN: A Controlled Clinical Trial and Laboratory InvestigationsThe Lancet, 1966
- PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)The Lancet, 1963
- NEW ANTIVIRAL CHEMOTHERAPEUTIC AGENT ACTIVE AGAINST SMALLPOX INFECTIONThe Lancet, 1960